Targeted nanoparticles show 80% success in treating ovarian cancer

MIT scientists have designed nanoparticles that could make cancer immunotherapy work better against ovarian tumors, one of the most treatment-resistant cancers.

The new system delivers an immune-activating molecule called IL-12 directly to…